Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500115794Phase 3Not yet recruiting
Phase 3, randomised trial of ciprofol in postoperative delirium (POD) and Postoperative neurocognitive disorder (PND) (2 arms), sponsored by Heji Hospital Affiliated to Changzhi Medical College. Primary endpoint: Incidence of postoperative delirium at 7 days. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500115794.